10+ YOEMS (~10+ yrs) or BS (~12+ yrs) industry experience; leadership in statistical programming, clinical development knowledge, regulatory standards, talent recruitment/retention, and process transformation.
Servier: Independent global pharmaceutical group developing innovative treatments for patients.
8+ YOEMasters in statistics/engineering or related field, minimum 8 years statistical programming/biostatistics in pharma, proficient in SAS and CDISC (ADaM/SDTM), strong regulatory knowledge and study management skills.
United States or Atlanta or Austin or Houston or Raleigh or Phoenix or Boston or Minneapolis or Dallas
$90k-$100k/yrRemoteFull Time
LivaNovaNASDAQ: LIVN: Manufactures medical devices for cardiac and neurological therapies.
Bachelor's in a quantitative field, relevant clinical trial/statistical programming experience, strong SAS skills, knowledge of SDTM/ADaM and programming QC, ability to produce validated, well-documented code and collaborate with cross-functional teams.
SAS, SAS Enterprise Guide, R, Python, SQL, Git, CDISC, SDTM, ADaM
Cambridge or Alaska or Arizona or Hawaii or Michigan or Tennessee
$188k-$211k/yrRemoteFull Time
Amylyx PharmaceuticalsNASDAQ: AMLX: Develops treatments for neurodegenerative diseases and endocrine conditions.
6+ YOEMS in Statistics/CS (6+ years SAS pharma) or BS (8+ years); expert SAS and CDISC (SDTM/ADaM); FDA/ICH regulatory experience; R preferred; ability to lead statistical programming for clinical trials and submissions.
SanofiEuronext Paris: SAN: Researches, develops, and manufactures medicines and vaccines globally.
5+ YOEPhD or MS in statistics with 5+ years pharmaceutical clinical development; SAS or R; strong project management and communication; English proficiency.
Cambridge or Spain or United Kingdom or Netherlands
RemoteFull Time
Cytel: Provides clinical trial design software and biostatistical consulting services.
8+ YOEBachelor's in statistics/CS/math,8+ years SAS clinical trial programming experience,study lead experience,CDISC SDTM/ADaM expertise,QC/validation and submission document experience.
Bristol Myers SquibbNew York Stock Exchange: BMY: Develops and distributes innovative medicines for serious diseases.
15+ YOE6+ MgmtLead the Target Sciences team in statistical genetics; 15+ years experience (or 12+ with MS, 8+ with PhD); leadership experience; PhD preferred; strong programming (R/Python)
AstraZenecaLondon Stock Exchange: AZN: Global biopharmaceutical developing and manufacturing prescription medicines.
10+ YOE7+ Mgmt10+ years statistical programming experience, 7+ years people/project management, advanced SAS skills, knowledge of CDISC SDTM/ADaM and eCTD submissions, budget and vendor management, leadership and cross-functional collaboration.
King of Prussia or Maidenhead or Waltham or Glattbrugg
$239k-$308k/yrOnsiteFull Time
CSLASX: CSL: Develops and manufactures biopharmaceutical products and vaccines.
10+ YOE5+ MgmtBSc in Computer Science/Math/Statistics or equivalent, 10+ years industry experience in biotech/pharma/CRO, 5+ years supervisory experience preferred, advanced SAS and CDISC knowledge, CRO management experience, strong communication and leadership skills.
MapLight TherapeuticsNASDAQ: MPLT: Develops targeted drug therapies for central nervous system disorders.
8+ YOEMaster’s in statistics, computer science or related field; 8+ years statistical programming in pharma/biotech; SAS expert; CDISC SDTM/ADaM; CRO management; FDA/ICH knowledge.
Alnylam PharmaceuticalsNASDAQ: ALNY: Develops RNAi therapeutics to treat rare and common diseases.
3+ YOEPhD in statistical genetics or related field with ≥3 years postdoc/industry experience; deep GWAS/RVAS expertise; experience with REGENIE, PLINK, METAL; proficiency in Linux, Python, and R; biobank-scale data experience.
REGENIE, PLINK, METAL, RAREMETAL, REMETA, SKAT, Linux, Python, R, DNAnexus, All of Us Researcher Workbench, Terra
RegeneronNasdaq: REGN: Discovers and manufactures medicines for serious diseases.
3+ YOEMaster's degree, 3+ years programming experience, proficiency with SAS, ability to lead programming and QC for clinical study analysis datasets and TFLs.
Vertex PharmaceuticalsNASDAQ: VRTX: Develops and sells prescription drugs for serious genetic diseases.
8+ YOEB.S. in a scientific discipline, 8+ years clinical programming experience, proficiency with SAS and CDISC, eCTD submission experience, strong communication and project skills.
AstraZenecaLondon Stock Exchange: AZN: Researches and develops medicines to treat major diseases globally.
10+ YOELead strategic direction of statistical programming; 10+ years in programming strategy; AI/automation; leadership; outsourcing experience; CDISC standards.
AlnylamNasdaq: ALNY: Developing and commercializing RNA interference (RNAi) therapeutics for diseases.
10+ YOE10+ years SAS programming experience in pharma/biotech/CRO, experience leading programming teams, CDISC (SDTM/ADaM) knowledge, proficiency in R and SAS, strong communication and organization.
Kura OncologyNASDAQ: KURA: Develops precision small molecule medicines for cancer treatment.
10+ YOE10+ years clinical programming experience; MS (or BS with additional experience) in quantitative field; advanced SAS skills; CDISC, ICH, GCP, 21 CFR Part 11 knowledge; experience with regulatory submissions; mentoring and vendor management experience.